(Invest in China) Fenomei plans to invest approximately 100 million yuan to expand and upgrade its Tianjin base
Quick Look
Phenomax, a global chromatography innovator, announced that it will invest approximately RMB 100 million to expand its Tianjin base, aiming to enhance its manufacturing capabilities for liquid chromatography columns and chromatography packings, and create approximately 30 new jobs to support localized supply in fields such as nucleic acid medicine.
AI-generated summary
Why It Matters
Feinomei is a member of Danaher China Life Sciences Platform and focuses on chromatographic separation and analysis technology. The base has been operating in Tianjin for ten years and will set up a R&D center in 2025.
China News Service, Tianjin, November 9 (Sun Yifei) Global chromatography innovator Feinome announced in Tianjin on the 9th that it plans to invest approximately 100 million yuan to expand and upgrade the production line of its Tianjin base to enhance its manufacturing capabilities of liquid chromatography columns and chromatography packing.
This upgrade will use existing space to release production capacity potential and is expected to create approximately 30 new jobs. After the project is completed, it will provide a more stable and reliable supply of localized products for nucleic acid medicine and other fields.
Phenomax is now a member of Danaher China Life Sciences Platform. Danaher is a multinational life sciences and medical diagnostics company headquartered in the United States; Feinome focuses on chromatographic separation and analysis technologies and products.
Lan Jun, General Manager of Phenomax China, said that he hopes Phenomax can play a bridge role, on the one hand, to better introduce Danaher's global technical resources to Tianjin and China, and on the other hand, to promote local production, R&D capabilities and innovation results to go global.
Hu Xiangyu, president of Danaher China Life Sciences Platform, said that China has unique advantages in speed and scale, which provides a good foundation for companies to accelerate localized innovation and capacity building. Danaher will continue to increase investment in innovation in Tianjin, link up industry, academia and research to build an industrial ecosystem, and promote more innovative results derived from China's needs to serve the global market.
This year marks the tenth anniversary of Finomax joining the Danaher Group. In the past ten years, the production efficiency of Feinomei's Tianjin base has increased by nearly 7 times, and the output value has increased by 2.6 times. In 2025, Fenomei's second R&D center in the world and Asia's first will be unveiled in Tianjin. At present, the localization rate of Feinomei's Tianjin base exceeds 93%.
What to Watch
AI outlook — possibilities, not facts
Feinomei will add about 30 jobs at its Tianjin base
Very likely · Within months
Open Questions
- What is the specific completion timetable for the expansion project?
